Dr. Mark Barakat discusses developments in gene therapy for neovascular AMD

/ , /by

Watch Dr. Mark Barakat discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD.